BEIJING, Sept 17 (Reuters) – AstraZeneca unveiled an investment of nearly 200 million yuan ($29.81 million) to upgrade its production and supply base in Wuxi, China, the company's Chinese unit said in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Eduardo Baptista and Laurie Chen BEIJING, Sept 17 (Reuters) - An AI system that…
(.) MUMBAI, Sept 17 (Reuters) - STOCKS: The benchmark BSE Sensex was up 0.2% at…
VIDEO SHOWS: HIGHLIGHTS FROM NEW YORK YANKEES V BALTIMORE ORIOLES MLB GAME COMPLETE SHOTLIST TO…
* Foreign students barred from bringing partners and children * Ballots to be introduced for…
A look at the day ahead in European and global markets from Stella Qiu Turns…
* Analysts estimate Asian LNG demand will fall 3% to 10% from 2025 levels in…